ResearcherGarvan Institute of Medical ResearchActive in the last 2 years
Roger J. Daly
Matched on ORCID iD 0000-0002-5739-8027; OpenAlex author ID A5060521527. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 33
2012: 2 papers · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 6
- EPHA2 and WNT reciprocally regulate MAPK-dependent gene expression in a pancreatic cancer model. Co-author DOI 10.1172/jci.insight.202630↗
- Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin status. Co-author DOI 10.1126/sciadv.abh0363↗
- HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer. Co-author DOI 10.1016/j.celrep.2020.107625↗
- Resolution of Novel Pancreatic Ductal Adenocarcinoma Subtypes by Global Phosphotyrosine Profiling. Last author DOI 10.1074/mcp.m116.058313↗
- Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Co-author DOI 10.1038/nature11547↗
- RON is not a prognostic marker for resectable pancreatic cancer. Co-author DOI 10.1186/1471-2407-12-395↗
Closest collaborators
The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shawn R. Wadia · 1 shared paper, 2026 · strength 0.33
- David M. Virshup · 1 shared paper, 2026 · strength 0.33
- Babita Madan · 1 shared paper, 2026 · strength 0.33
- Andrew Victor Biankin · 3 shared papers, 2012–2021 · strength 0.16
- Paper Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin s… DOI 10.1126/sciadv.abh0363↗
- Paper Resolution of Novel Pancreatic Ductal Adenocarcinoma Subtypes by Global Phosphotyrosine Profiling. DOI 10.1074/mcp.m116.058313↗
- Paper RON is not a prognostic marker for resectable pancreatic cancer. DOI 10.1186/1471-2407-12-395↗
- Marina Pajic · 2 shared papers, 2016–2021 · strength 0.13
- Angela S. Y. Chou · 2 shared papers, 2012–2021 · strength 0.11
- Sean Michael Grimmond · 2 shared papers, 2012–2021 · strength 0.11
- Anthony James Gill · 2 shared papers, 2012–2021 · strength 0.11
- Emily S. Humphrey · 2 shared papers, 2012–2016 · strength 0.08
- David Kuang-Fu Chang · 2 shared papers, 2012–2016 · strength 0.08
- Yingxiao Wang · 1 shared paper, 2021 · strength 0.08
- Ashleigh Parkin · 1 shared paper, 2021 · strength 0.08
- Michael Tayao · 1 shared paper, 2021 · strength 0.08
- Jaswinder Singh Samra · 1 shared paper, 2021 · strength 0.08
- Claire Vennin · 1 shared paper, 2021 · strength 0.08
- Shona Ritchie · 1 shared paper, 2021 · strength 0.08
- Thomas R. Cox · 1 shared paper, 2021 · strength 0.08
- Max Nobis · 1 shared paper, 2021 · strength 0.08
- Amber L. Johns · 1 shared paper, 2021 · strength 0.08
- Kendelle Joan Murphy · 1 shared paper, 2021 · strength 0.08
- Cecilia R. Chambers · 1 shared paper, 2021 · strength 0.08
- David Herrmann · 1 shared paper, 2021 · strength 0.08
- Brooke Pereira · 1 shared paper, 2021 · strength 0.08
- James R. W. Conway · 1 shared paper, 2021 · strength 0.08
- Australian Pancreatic Cancer Genome Initiative (APGI) · 1 shared paper, 2021 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.